» Articles » PMID: 32258206

Septic Arthritis and the Opioid Epidemic: 1465 Cases of Culture-Positive Native Joint Septic Arthritis From 1990-2018

Overview
Date 2020 Apr 8
PMID 32258206
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The clinical spectrum of septic arthritis in the era of the opioid crisis is ill-defined.

Methods: This is a retrospective chart review of 1465 cases of culture-positive native joint septic arthritis at Boston teaching hospitals between 1990 and 2018.

Results: Between 1990-2008 and 2009-2018, the proportion of septic arthritis cases involving people who inject drugs (PWID) rose from 10.3% to 20% ( < .0000005). Overall, methicillin-sensitive (MSSA) caused 41.5% of cases, and methicillin-resistant (MRSA) caused 17.9%. Gram-negative rods caused only 6.2% of cases. Predictors of MRSA septic arthritis included injection drug use ( < .001), bacteremia ( < .001), health care exposure ( < .001), and advancing age ( = .01). Infections with MSSA were more common in PWID (56.3% vs 38.8%;  < .00001), as were infections with MRSA (24% vs 16.8%;  = .01) and sp. (4% vs 0.4%;  = .002). Septic arthritis in the setting of injection drug use was significantly more likely to involve the sacroiliac, acromioclavicular, and facet joints; 36.8% of patients had initial synovial fluid cell counts of <50 000 cells/mm.

Conclusions: Injection drug use has become the most common risk factor for septic arthritis in our patient population. Septic arthritis in PWID is more often caused by MRSA, MSSA, and sp., and is more prone to involve the sacroiliac, acromioclavicular, sternoclavicular, and facet joints. Synovial fluid cell counts of <50000 cells/mm are common in culture-positive septic arthritis.

Citing Articles

Injection drug use is associated with repeat irrigation and debridement in native joint septic arthritis.

Linden G, Lipson S, Desai V, Krivicich L, Puzzitiello R, Gabriel D J Orthop. 2024; 64:18-22.

PMID: 39651339 PMC: 11617899. DOI: 10.1016/j.jor.2024.11.006.


Effect of Preoperative Antibiotic Therapy on Operative Culture Yield for Diagnosis of Native Joint Septic Arthritis.

Khodadadi R, Damronglerd P, McHugh J, El Zein S, Lahr B, Yuan B Clin Infect Dis. 2024; 79(4):1062-1070.

PMID: 38466824 PMC: 11478806. DOI: 10.1093/cid/ciae136.


Septic Arthritis of the Spinal Facet Joint: Review of 117 Cases.

Ross J, Ard K Open Forum Infect Dis. 2024; 11(3):ofae091.

PMID: 38449920 PMC: 10917203. DOI: 10.1093/ofid/ofae091.


Assessment of Bacterial Infections and Antibiotic Regimens in Intravenous Drug Users.

Rehman S, Arif S, Ushakumari L, Amreen J, Nagelli A, Moonnumackel S Cureus. 2023; 15(9):e45716.

PMID: 37868523 PMC: 10590200. DOI: 10.7759/cureus.45716.


An update on recent progress of the epidemiology, etiology, diagnosis, and treatment of acute septic arthritis: a review.

He M, Vithran D, Pan L, Zeng H, Yang G, Lu B Front Cell Infect Microbiol. 2023; 13:1193645.

PMID: 37249986 PMC: 10214960. DOI: 10.3389/fcimb.2023.1193645.


References
1.
Dubost J, Couderc M, Tatar Z, Tournadre A, Lopez J, Mathieu S . Three-decade trends in the distribution of organisms causing septic arthritis in native joints: single-center study of 374 cases. Joint Bone Spine. 2014; 81(5):438-40. DOI: 10.1016/j.jbspin.2014.05.001. View

2.
Mathews C, Weston V, Jones A, Field M, Coakley G . Bacterial septic arthritis in adults. Lancet. 2010; 375(9717):846-55. DOI: 10.1016/S0140-6736(09)61595-6. View

3.
Serota D, Niehaus E, Schechter M, Jacob J, Jones J, Ray S . Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated Bacteremia. Open Forum Infect Dis. 2019; 6(7):ofz289. PMC: 6612813. DOI: 10.1093/ofid/ofz289. View

4.
Munoz-Egea M, Blanco A, Fernandez-Roblas R, Gadea I, Garcia-Canete J, Sandoval E . Clinical and microbiological characteristics of patients with septic arthritis: A hospital-based study. J Orthop. 2014; 11(2):87-90. PMC: 4118572. DOI: 10.1016/j.jor.2014.04.002. View

5.
Nuorti J, Butler J, Farley M, Harrison L, McGeer A, Kolczak M . Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000; 342(10):681-9. DOI: 10.1056/NEJM200003093421002. View